{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2016-N-0002\" sorted by posted_date descending", "rows": [["FDA-2016-N-0002-0048", "FDA", "FDA-2016-N-0002", "Hospira, Inc. et al.; Withdrawal of Approval of 44 New Drug Applications\nand 158 Abbreviated New Drug Applications; Correction", "Notice", "Correction", "2018-02-13T05:00:00Z", 2018, 2, "2018-02-13T05:00:00Z", null, "2018-02-13T15:05:16Z", "2018-02926", 0, 0, "0900006482f279da"], ["FDA-2016-N-0002-0047", "FDA", "FDA-2016-N-0002", "Hospira, Inc. et al.; Withdrawal of Approval of 44 New Drug Applications\nand 158 Abbreviated New Drug Applications; Correction", "Notice", "Correction", "2017-07-18T04:00:00Z", 2017, 7, "2017-07-18T04:00:00Z", null, "2017-07-18T14:50:54Z", "2017-15003", 0, 0, "090000648293b5a7"], ["FDA-2016-N-0002-0041", "FDA", "FDA-2016-N-0002", "FOI Summary oA 200-589 approved December 21 2016", "Supporting & Related Material", "Background Material", "2017-03-01T05:00:00Z", 2017, 3, null, null, "2017-03-01T17:59:40Z", null, 0, 0, "09000064824e4a20"], ["FDA-2016-N-0002-0042", "FDA", "FDA-2016-N-0002", "FOI Summary oN 141-473 approved December 16 2016", "Supporting & Related Material", "Background Material", "2017-03-01T05:00:00Z", 2017, 3, null, null, "2017-03-01T18:00:21Z", null, 0, 0, "09000064824e4a21"], ["FDA-2016-N-0002-0043", "FDA", "FDA-2016-N-0002", "FOI Summary oN 141-474 approved November 10 2016", "Supporting & Related Material", "Background Material", "2017-03-01T05:00:00Z", 2017, 3, null, null, "2017-03-01T18:00:55Z", null, 0, 0, "09000064824e4dd9"], ["FDA-2016-N-0002-0045", "FDA", "FDA-2016-N-0002", "FOI Summary sN 141-443, approved November 16, 2016", "Supporting & Related Material", "Background Material", "2017-03-01T05:00:00Z", 2017, 3, null, null, "2017-03-01T18:02:03Z", null, 0, 0, "09000064824e4ddb"], ["FDA-2016-N-0002-0044", "FDA", "FDA-2016-N-0002", "FOI Summary oN 141-475 approved December 29 2016", "Supporting & Related Material", "Background Material", "2017-03-01T05:00:00Z", 2017, 3, null, null, "2017-03-01T18:01:29Z", null, 0, 0, "09000064824e4dda"], ["FDA-2016-N-0002-0046", "FDA", "FDA-2016-N-0002", "FOI Summary sN 141-452 approved December 12 2016", "Supporting & Related Material", "Background Material", "2017-03-01T05:00:00Z", 2017, 3, null, null, "2017-03-01T18:02:38Z", null, 0, 0, "09000064824e4ddc"], ["FDA-2016-N-0002-0040", "FDA", "FDA-2016-N-0002", "New Animal Drugs: Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of Sponsor; Change of Sponsor's Name", "Rule", "Final Rule", "2017-03-01T05:00:00Z", 2017, 3, "2017-03-01T05:00:00Z", null, "2017-03-01T15:12:02Z", "2017-03930", 0, 0, "09000064824e380d"], ["FDA-2016-N-0002-0037", "FDA", "FDA-2016-N-0002", "New Animal Drugs; Withdrawal of Approval of New Animal Drug Applications", "Rule", "Withdrawal", "2017-02-24T05:00:00Z", 2017, 2, "2017-02-24T05:00:00Z", null, "2017-02-24T16:18:39Z", "2017-03595", 0, 0, "09000064824d99cf"], ["FDA-2016-N-0002-0038", "FDA", "FDA-2016-N-0002", "New Animal Drugs; Withdrawal of Approval of a New Animal Drug Application", "Rule", "Withdrawal", "2017-02-24T05:00:00Z", 2017, 2, "2017-02-24T05:00:00Z", null, "2017-02-24T16:23:09Z", "2017-03678", 0, 0, "09000064824d99d6"], ["FDA-2016-N-0002-0039", "FDA", "FDA-2016-N-0002", "New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of a New Animal Drug Application; Change of Sponsor; Change of Sponsor\u2019s Address", "Rule", "Final Rule", "2017-02-24T05:00:00Z", 2017, 2, "2017-02-24T05:00:00Z", null, "2017-02-24T16:27:30Z", "2017-03677", 0, 0, "09000064824d9ac7"], ["FDA-2016-N-0002-0036", "FDA", "FDA-2016-N-0002", "New Animal Drugs for Use in Animal Feed; Approval of New Animal Drug\nApplications; Withdrawal of Approval of New Animal Drug Applications", "Rule", "Final Rule", "2017-02-24T05:00:00Z", 2017, 2, "2017-02-24T05:00:00Z", null, "2017-02-24T16:12:09Z", "2017-03596", 0, 0, "09000064824d9933"], ["FDA-2016-N-0002-0035", "FDA", "FDA-2016-N-0002", "Abbott Laboratories, et al.; Withdrawal of Approval of Four New Drug\nApplications and Two Abbreviated New Drug Applications", "Notice", "Withdrawal", "2016-12-29T05:00:00Z", 2016, 12, "2016-12-29T05:00:00Z", null, "2016-12-29T15:02:22Z", "2016-31625", 0, 0, "090000648243d2a9"], ["FDA-2016-N-0002-0034", "FDA", "FDA-2016-N-0002", "Oral Dosage Form New Animal Drugs; Approval of New Animal Drug \nApplications", "Rule", "Final Rule", "2016-12-27T05:00:00Z", 2016, 12, "2016-12-27T05:00:00Z", null, "2016-12-27T15:20:22Z", "2016-31084", 0, 0, "0900006482437617"], ["FDA-2016-N-0002-0033", "FDA", "FDA-2016-N-0002", "New Animal Drugs; Withdrawal of Approval of New Animal Drug Applications", "Rule", "Withdrawal", "2016-12-27T05:00:00Z", 2016, 12, "2016-12-27T05:00:00Z", null, "2016-12-27T14:40:37Z", "2016-31082", 0, 0, "09000064824374ac"], ["FDA-2016-N-0002-0032", "FDA", "FDA-2016-N-0002", "New Animal Drugs for Use in Animal Feed; Approval of New Animal \nDrug Applications; Withdrawal of Approval of New Animal Drug Applications", "Rule", "Final Rule", "2016-12-27T05:00:00Z", 2016, 12, "2016-12-27T05:00:00Z", null, "2016-12-27T13:37:48Z", "2016-31083", 0, 0, "090000648243727b"], ["FDA-2016-N-0002-0031", "FDA", "FDA-2016-N-0002", "Hospira, Inc. et al.; Withdrawal of Approval of 44 New Drug Applications\nand 158 Abbreviated New Drug Applications", "Notice", "Withdrawal", "2016-10-04T04:00:00Z", 2016, 10, "2016-10-04T04:00:00Z", null, "2016-10-04T16:14:57Z", "2016-23893", 0, 0, "0900006482291438"], ["FDA-2016-N-0002-0030", "FDA", "FDA-2016-N-0002", "New Animal Drugs: Approval of New Animal Drug Applications; Change of Sponsor's Address", "Rule", "Final Rule", "2016-09-30T04:00:00Z", 2016, 9, "2016-09-30T04:00:00Z", null, "2016-09-30T13:43:41Z", "2016-23230", 0, 0, "0900006482284ad3"], ["FDA-2016-N-0002-0029", "FDA", "FDA-2016-N-0002", "New Animal Drugs for Use in Animal Feeds: Chlortetracycline and Sulfamethazine; Chlortetracycline, Procaine Penicillin, and Sulfamethazine", "Rule", "Final Rule", "2016-09-14T04:00:00Z", 2016, 9, "2016-09-14T04:00:00Z", null, "2016-09-14T13:59:59Z", "2016-21985", 0, 0, "090000648220a1e1"], ["FDA-2016-N-0002-0028", "FDA", "FDA-2016-N-0002", "Withdrawal of Approval of Part of a New Animal Drug Application;\nChlortetracycline, Procaine Penicillin, and Sulfamethazine", "Notice", "Withdrawal", "2016-09-14T04:00:00Z", 2016, 9, "2016-09-14T04:00:00Z", null, "2016-09-14T13:36:10Z", "2016-21984", 0, 0, "0900006482209c71"], ["FDA-2016-N-0002-0019", "FDA", "FDA-2016-N-0002", "New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Changes of \nSponsorship; Change of Sponsor's Name and Address; Change of Sponsor's \nAddress", "Rule", "Correction", "2016-08-29T04:00:00Z", 2016, 8, "2016-08-29T04:00:00Z", null, "2016-08-29T15:36:17Z", "2016-19914", 0, 0, "09000064821a8156"], ["FDA-2016-N-0002-0027", "FDA", "FDA-2016-N-0002", "FOI Summary oA 200-596, approved May 24, 2016 re  New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship", "Supporting & Related Material", "Background Material", "2016-08-29T04:00:00Z", 2016, 8, null, null, "2016-08-29T16:11:19Z", null, 0, 0, "09000064821a95b5"], ["FDA-2016-N-0002-0026", "FDA", "FDA-2016-N-0002", "FOI Summary oN 141-463, approved May 17, 2016 re New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship", "Supporting & Related Material", "Background Material", "2016-08-29T04:00:00Z", 2016, 8, null, null, "2016-08-29T16:08:53Z", null, 0, 0, "09000064821a95b4"], ["FDA-2016-N-0002-0020", "FDA", "FDA-2016-N-0002", "EA oN 141-439, approved May 2, 2016 re New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship", "Supporting & Related Material", "Background Material", "2016-08-29T04:00:00Z", 2016, 8, null, null, "2016-08-29T15:55:41Z", null, 0, 0, "09000064821a95ae"], ["FDA-2016-N-0002-0018", "FDA", "FDA-2016-N-0002", "New Animal Drugs for Use in Animal Feed; Withdrawal of Approval of a New Animal Drug Application", "Rule", "Withdrawal", "2016-08-29T04:00:00Z", 2016, 8, "2016-08-29T04:00:00Z", null, "2016-08-29T15:26:57Z", "2016-19915", 0, 0, "09000064821a7b65"], ["FDA-2016-N-0002-0022", "FDA", "FDA-2016-N-0002", "FOI Summary oA 200-587, approved June 20, 2016 re New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship", "Supporting & Related Material", "Background Material", "2016-08-29T04:00:00Z", 2016, 8, null, null, "2016-08-29T15:54:56Z", null, 0, 0, "09000064821a95b0"], ["FDA-2016-N-0002-0021", "FDA", "FDA-2016-N-0002", "FOI Summary oA 200-536, approved May 17, 2016 re New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship", "Supporting & Related Material", "Background Material", "2016-08-29T04:00:00Z", 2016, 8, null, null, "2016-08-29T15:56:15Z", null, 0, 0, "09000064821a95af"], ["FDA-2016-N-0002-0024", "FDA", "FDA-2016-N-0002", "FOI Summary oN 141-439, approved May 2, 2016 re New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship", "Supporting & Related Material", "Background Material", "2016-08-29T04:00:00Z", 2016, 8, null, null, "2016-08-29T16:04:28Z", null, 0, 0, "09000064821a95b2"], ["FDA-2016-N-0002-0025", "FDA", "FDA-2016-N-0002", "FOI Summary oN 141-457, approved May 16, 2016 re New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship", "Supporting & Related Material", "Background Material", "2016-08-29T04:00:00Z", 2016, 8, null, null, "2016-08-29T16:06:08Z", null, 0, 0, "09000064821a95b3"], ["FDA-2016-N-0002-0023", "FDA", "FDA-2016-N-0002", "FOI Summary oA 200-596, approved May 24, 2016 re New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship", "Supporting & Related Material", "Background Material", "2016-08-29T04:00:00Z", 2016, 8, null, null, "2016-08-29T16:03:00Z", null, 0, 0, "09000064821a95b1"], ["FDA-2016-N-0002-0017", "FDA", "FDA-2016-N-0002", "Finding of No Significant Impact (FONSI) for IMRESTOR (pegbovigrastim injection) in Dairy Cattle", "Supporting & Related Material", "Background Material", "2016-06-08T04:00:00Z", 2016, 6, null, null, "2016-06-13T21:06:34Z", null, 0, 0, "0900006482021116"], ["FDA-2016-N-0002-0012", "FDA", "FDA-2016-N-0002", "New Animal Drugs: Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Changes of Sponsorship", "Rule", "Final Rule", "2016-06-08T04:00:00Z", 2016, 6, "2016-06-08T04:00:00Z", null, "2016-06-08T14:03:11Z", "2016-13517", 0, 0, "090000648201e0ff"], ["FDA-2016-N-0002-0014", "FDA", "FDA-2016-N-0002", "FREEDOM OF INFORMATION SUMMARY ORIGINAL NEW ANIMAL DRUG APPLICATION NADA 141-392 IMRESTOR", "Supporting & Related Material", "Background Material", "2016-06-08T04:00:00Z", 2016, 6, null, null, "2016-06-13T21:06:14Z", null, 0, 0, "0900006482021113"], ["FDA-2016-N-0002-0013", "FDA", "FDA-2016-N-0002", "Environmental Assessment of PEGylated bovine granulocyte colony stimulating factor (PEG bG-CSF) for Dairy Cows (USA)", "Supporting & Related Material", "Background Material", "2016-06-08T04:00:00Z", 2016, 6, null, null, "2016-06-13T21:06:06Z", null, 0, 0, "0900006482021112"], ["FDA-2016-N-0002-0015", "FDA", "FDA-2016-N-0002", "FREEDOM OF INFORMATION SUMMARY ORIGINAL NEW ANIMAL DRUG APPLICATION NADA 141-455 GALLIPRANT", "Supporting & Related Material", "Background Material", "2016-06-08T04:00:00Z", 2016, 6, null, null, "2016-06-13T21:06:21Z", null, 0, 0, "0900006482021114"], ["FDA-2016-N-0002-0016", "FDA", "FDA-2016-N-0002", "FREEDOM OF INFORMATION SUMMARY ORIGINAL NEW ANIMAL DRUG APPLICATION NADA 141-460 AIVLOSIN 17% Tylvalosin Type A Medicated Article Swine", "Supporting & Related Material", "Background Material", "2016-06-08T04:00:00Z", 2016, 6, null, null, "2016-06-13T21:06:27Z", null, 0, 0, "0900006482021115"], ["FDA-2016-N-0002-0011", "FDA", "FDA-2016-N-0002", "New Animal Drugs; Withdrawal of Approval of a New Animal Drug\nApplication", "Rule", "Withdrawal", "2016-06-08T04:00:00Z", 2016, 6, "2016-06-08T04:00:00Z", null, "2016-06-08T13:29:59Z", "2016-13518", 0, 0, "090000648201df5b"], ["FDA-2016-N-0002-0010", "FDA", "FDA-2016-N-0002", "New Animal Drugs: Approval of New Animal Drug Applications; Changes of Sponsorship; Correction", "Rule", "Final Rule", "2016-04-28T04:00:00Z", 2016, 4, "2016-04-28T04:00:00Z", null, "2016-04-28T16:16:35Z", "2016-09865", 0, 0, "0900006481f94e7f"], ["FDA-2016-N-0002-0007", "FDA", "FDA-2016-N-0002", "FOI Summary NADA 141-263 re New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship", "Supporting & Related Material", "Background Material", "2016-04-18T04:00:00Z", 2016, 4, null, null, "2016-05-05T22:45:37Z", null, 0, 0, "0900006481f71386"], ["FDA-2016-N-0002-0001", "FDA", "FDA-2016-N-0002", "New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship", "Rule", "Correction", "2016-04-18T04:00:00Z", 2016, 4, "2016-04-18T04:00:00Z", null, "2016-04-18T16:03:25Z", "2016-08827", 0, 0, "0900006481f705dc"], ["FDA-2016-N-0002-0009", "FDA", "FDA-2016-N-0002", "FONSI 141-449 SAFE-GUARD AQUASOL (fenbendazole oral suspension) in Swine except for nursing piglets re New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship", "Supporting & Related Material", "Background Material", "2016-04-18T04:00:00Z", 2016, 4, null, null, "2016-05-05T22:45:55Z", null, 0, 0, "0900006481f7139d"], ["FDA-2016-N-0002-0004", "FDA", "FDA-2016-N-0002", "FOI Summary NADA 141-444 re New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship", "Supporting & Related Material", "Background Material", "2016-04-18T04:00:00Z", 2016, 4, null, null, "2016-05-05T22:45:11Z", null, 0, 0, "0900006481f710c4"], ["FDA-2016-N-0002-0005", "FDA", "FDA-2016-N-0002", "FOI Summary NADA 141-448 re New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship", "Supporting & Related Material", "Background Material", "2016-04-18T04:00:00Z", 2016, 4, null, null, "2016-05-05T22:45:22Z", null, 0, 0, "0900006481f710c5"], ["FDA-2016-N-0002-0008", "FDA", "FDA-2016-N-0002", "FOI Summary NADA 141-449 re New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship", "Supporting & Related Material", "Background Material", "2016-04-18T04:00:00Z", 2016, 4, null, null, "2016-05-05T22:45:46Z", null, 0, 0, "0900006481f71389"], ["FDA-2016-N-0002-0002", "FDA", "FDA-2016-N-0002", "Environmental Assessment re New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship", "Supporting & Related Material", "Background Material", "2016-04-18T04:00:00Z", 2016, 4, null, null, "2016-05-05T22:44:59Z", null, 0, 0, "0900006481f710be"], ["FDA-2016-N-0002-0006", "FDA", "FDA-2016-N-0002", "FOI Summary NADA 141-452 re New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship", "Supporting & Related Material", "Background Material", "2016-04-18T04:00:00Z", 2016, 4, null, null, "2016-05-05T22:45:29Z", null, 0, 0, "0900006481f71323"], ["FDA-2016-N-0002-0003", "FDA", "FDA-2016-N-0002", "FOI Original Abbreviated New Animal Drug Application re New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship", "Supporting & Related Material", "Background Material", "2016-04-18T04:00:00Z", 2016, 4, null, null, "2016-05-05T22:44:52Z", null, 0, 0, "0900006481f710c3"]], "truncated": false, "filtered_table_rows_count": 48, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 order by posted_date desc limit 101", "params": {"p0": "FDA-2016-N-0002"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2016-N-0002", "results": [{"value": "FDA", "label": "FDA", "count": 48, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-2016-N-0002&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2016-N-0002", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 27, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-2016-N-0002&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Rule", "label": "Rule", "count": 16, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-2016-N-0002&document_type=Rule", "selected": false}, {"value": "Notice", "label": "Notice", "count": 5, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-2016-N-0002&document_type=Notice", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2016-N-0002", "results": [{"value": 2016, "label": 2016, "count": 35, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-2016-N-0002&posted_year=2016", "selected": false}, {"value": 2017, "label": 2017, "count": 12, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-2016-N-0002&posted_year=2017", "selected": false}, {"value": 2018, "label": 2018, "count": 1, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-2016-N-0002&posted_year=2018", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-2016-N-0002&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-2016-N-0002&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-2016-N-0002&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-2016-N-0002&_facet=comment_start_date"}, {"name": "posted_date", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-2016-N-0002&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-2016-N-0002&_facet_date=comment_start_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-2016-N-0002&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 1810.1610410958529, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}